Skip to content
Open access

Disassembly of mitochondrial cristae architecture drives neurodegeneration in Huntington’s disease

Oct 2026 · Molecular Neurodegeneration · 0 citations

TL;DR

These findings identify mitochondrial cristae architecture as a point of vulnerability in neurodegeneration and establish architectural destabilization of organelles as an upstream pathogenic mechanism linking disease proteins to neuronal degeneration.

Abstract

Mitochondrial dysfunction is a key feature of many neurodegenerative diseases, including Huntington’s disease (HD), yet the initiating cellular lesion that links the disease-causing protein, mutant huntingtin (mtHtt), to organelle failure and neuronal degeneration remains unclear. Using complementary in vitro and in vivo models of HD, we investigated the molecular mechanisms by which mtHtt disrupts mitochondrial integrity and identified its mitochondrial target whose perturbation leads to cristae disorganization and subsequent neuronal degeneration. The pathogenic relevance of this pathway was further evaluated in HD patient iPSC-derived striatal neurons and HD knock-in mice through genetic manipulation, where behavioral assays, neuropathological analyses, and electron microscopy were employed to assess disease progression and mitochondrial ultrastructure. We show that mutant huntingtin (mtHtt) destabilizes mitochondrial membrane architecture through disruption of the mitochondrial contact site and cristae organizing system (MICOS). Across neuronal and mouse models HD, the MICOS complex is disassembled and its core scaffold protein mitofilin is depleted. Mechanistically, mtHtt accumulates at mitochondrial contact sites, associates with mitofilin, and recruits the AAA-ATPase VCP/p97, which drives ATPase-dependent extraction of mitofilin from MICOS, leading to cristae disorganization, respiratory impairment, and structural destabilization. Extracted mitofilin accumulates in insoluble assemblies with mtHtt and VCP, reducing the soluble pool required to maintain crista junctions. Blocking VCP mitochondrial recruitment or inhibiting its ATPase activity preserves MICOS integrity, while restoring mitofilin reconstitutes cristae architecture, improves mitochondrial and synaptic function in patient-derived neurons, and ameliorates neuropathology and motor deficits in HD mice. These findings identify mitochondrial cristae architecture as a point of vulnerability in neurodegeneration and establish architectural destabilization of organelles as an upstream pathogenic mechanism linking disease proteins to neuronal degeneration.

Read PDF

Similar papers

Review Nov 2026

Miro1 and mitochondrial dysfunction in Huntington's disease: Emerging mechanistic links and therapeutic perspectives.

Huntington's disease (HD) is a chronic, hereditary, and ultimately fatal neurological disorder that is transmitted in an autosomal dominant manner through an abnormal expansion of trinucleotide CAG repeats in the huntingtin gene, which encodes a mutant protein with an expanded polyglutamine tract. HD occurs in approxim...

Sanjeevan Gupta, Snehashis Mandal, Priti Dipa et al. · 0 citations
Review Oct 2026

Role of Miro1 in Mitochondrial Dysfunction and Neurodegeneration in Huntington's Disease.

INTRODUCTION Huntington's Disease (HD) is an autosomal dominant neurodegenerative disorder that is caused by expansion of Cytosine-Adenine-Guanine (CAG) repeats in the Huntingtin (HTT) gene and leads to progressive motor, cognitive, and psychiatric dysfunction. Mitochondrial dysfunction is a major pathological feature...

Mustak Ahamed, K. Aran · 1 citation
Review Sep 2026

Defective membrane dynamics in Huntington's disease: A role of Rab11 dysfunction.

Huntington's disease (HD) is a life-threatening neurodegenerative disease caused by a mutation in Huntingtin (HTT). Neuropathology in HD is marked by a progressive loss of neurons in the caudate putamen and the deposition of mutant HTT aggregates as cytoplasmic and nuclear inclusions. At present, no disease-modifying t...

An Wu, Xue-Yi Li · 0 citations
Review Open access Oct 2026

Mitophagy Dysfunction in Neurodegenerative Diseases: Molecular Mechanisms, Disease-Specific Pathways and Therapeutic Targets

Mitophagy is a specific type of autophagy that is crucial for neuronal survival and for the maintenance of mitochondrial quality. Dysfunction of it leads to the progression of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis. This revie...

Nidhi Saraswat, A. Singh, Y. Narkhede et al. · 0 citations
Review Open access Oct 2026

The “Invisible Killer” of Neurodegeneration: Mitochondrial Dysfunction in Neurodegenerative Disorders, Mechanisms, Emerging Pathways and Therapeutic Strategies

Abstract Neurodegenerative diseases such as Parkinson’s disease (PD), Alzheimer’s disease (AD), Huntington’s disease (HD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) place substantial burden on global public health. Mounting evidence identifies mitochondrial dysfunction as a central contributor to...

Song-Qian Cao, Ting-Ting Liu, Xiang-Shu Cheng et al. · 0 citations
Open access Oct 2026

KATNAL2 dysfunction impairs microtubule dynamics and contributes to syndromic neurodevelopmental disease

Abstract Katanins are microtubule-severing ATPases. Dysfunction of katanin subunits has been implicated in impaired neurogenesis, morphogenesis, and neuronal migration. Although heterozygous variants in KATNAL2 (katanin-like 2), a known autism-spectrum disorder (ASD) risk gene, have been reported in patients with ASD o...

Ece Sonmezler, Semra Hız Kurul, Ozlem Erez et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.